Excerpt: We write today to express our grave concern that the Commission continues to consider reclassifying Internet broadband service as an old-fashioned “Title II” common carrier service. Such unwarranted and overreaching government intrusion into the broadband marketplace will harm consumers, halt job creation, curtail investment, stifle innovation, and set America down a dangerous path of micromanaging the Internet. The Commission must reject this approach.
Excerpt: Efficient and effective management of the SPR is an important component of our nation’s energy security. As the summer driving season approaches and tensions in some of the world’s most resource-rich areas and elsewhere show no sign of abating, the obligation of Congress, and especially this committee, to remain vigilant in its oversight of DOE’s stewardship of this important program is clear.
Excerpt: In announcing the 2015 Rate Announcement for Medicare Advantage plans, CMS said it "estimates the overall net change to plan payments between 2014 and 2015 to be +.04 percent." However, most objective observers, including many market analysts and industry researchers, concluded that the overall net impact of the finalized changes actually amounts to approximately an over three percent cut to Medicare Advantage plans.
Excerpt: One goal of the incentive auction legislation was to bring market forces, via auctions, to bear on the question of how best to allocate spectrum resources. A pure market-based approach would allow all qualified bidders to freely bid on spectrum licenses, thereby determining whether broadcasting or commercial wireless is the highest economic use of the spectrum.
Excerpt: Thank you for your cooperation with the committee’s March 13 request on enrollment data. Due to the administration’s repeated delays and extensions, we believe additional data is required to determine who has enrolled and paid for a plan on the Federally-Facilitated Marketplace.
Excerpt: The process followed by FDA in proposing this rule appears to stand in stark contrast to the approach taken by the agency in developing changes to the content and format of prescription drug labeling under the Clinton administration.